Volume : 11, Issue : 01, January – 2024
Title:
A REVIEW ARTICLE ON ARTIFICIAL INTELLIGENCE IN PHARMA INDUSTRY AND HEALTH CARE SECTOR
Authors :
J. Jahnavi, Dr. K. Umasankar
Abstract :
Artificial Intelligence is the pharma’s &healthcare upcoming frontier in life science. Present digitalization of medicine &availability of [electronic health records] EHRs motivated the healthcare personnel to employ AI. Nowadays AI is needs in increasing production to gain the quality outcome. Current AI tendency in pharma field on several [artificial neural networks] ANNs such as [deep neural network] DNNs nor [recurrent neural network] RNNs & on [process analytical technology] PAT, [computational fluid dynamics] CFD &many more. As in healthcare AI have a tremendous role in storage of information & data management like patient case records, sale details, medicine holdings &so on. AI is checked or used on various healthcares, pharma industries & also included in disease identifying. Usage of A.I in pharmaceutical industry has accelerated. And by the usage of these A.I technologies can spare the time & money while supplying finer acknowledge on various process parameters & formulations. But at a time robot manufacturers has struggling with various challenges for their efforts to build themselves in pharmaceutical applications. A.I with robotics has a lot of advantages and disadvantages.
Keywords: Artificial Intelligence, Natural language processing, Personalized treatment, Telemedicine, Clinical trials, Hospital and community pharmacy.
Cite This Article:
Please cite this article in press J. Jahnavi et al., A Review Article On Artificial Intelligence In Pharma Industry And Health Care Sector, Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1. Sanjeeb Kumar Sahoo, Nihar Ranjan Kar. Applications of Artificial Intelligence in Pharmaceutical Industry and Healthcare Sector. Journal of Fundamental & Comparative Research.2022 Dec;2277-7067
2. Prerna V Surye.,et al., A Review on Artificial Intelligence in Pharmacy. International Journal of Pharmaceutical Research and Applications.2023 March, pp:1938-1946
3. Muhammad Ahmer Raza., et al., Artificial Intelligence in Pharmacy: An Overview of Innovations. Pharmacy Practice & Practice- Based Research.2022, pp: 1312-4839
4. Sudipto Datta.,et al., Application of Artificial Intelligence in Modern Healthcare System. Intech open.2019
5. Tamanna Sharma, Abhinav Mankoo., et al., Artificial Intelligence in Advanced Pharmacy. International Journal of Science & Research Archive,2021,02(01),047-054
6. Subrat Kumar Bhattamisra, et al., Artificial Intelligence in Pharmaceutical and Healthcare Research.2023, https://www.mdpi.com/journal/bdcc.
7. Artificial Intelligence in healthcare,Academy of Royal Medical Colleges,2019
8. Jiang F, Jiang Y., et al., Artificial Intelligence in Healthcare: past, present and future. Stroke Vasc Neurol.2017;2(4):230-43
9. Agrawal P. Artificial Intelligence in drug discovery and development. J Pharmacovigil.2018;6(2)
10. Das, S., R. Dey, and A.K Nayak, Artificial intelligence in pharmacy. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021. 55(2): P.304-318.
11. Russell, S., D. Dewey, and M. Tegmark, research priorities for robust and beneficial Artificial Intelligence: an open letter. AI Magazine, 2015.36(4)
12. Christopher DM, Hinrich S. Foundations of Statistical Natural Language Processing. Cambridge, London, England: The MIT Press; 1999
13. Afzal N, Sohn S, Abram S, et al. Mining peripheral arterial disease cases from narrative clinical notes using natural language processing. Journal of vascular Surgery. 2071;65:1753-1761
14. Castro VM, Dligach D, Finan S, et al. et al. Large-scale identification of patients with cerebral aneurysms using natural language processing. Neurology. 2017;88:164-168
15. Ramesh, A.N.; Kambhampati, C.; Monson, J.R.; Drew, P.J. Artificial Intelligence in medicine. Ann. R. Coll. Surg. Engl. 2004, 86, 334
16. Hanson III, C.W.; Marshall, B.E. Artificial Intelligence Applications in the intensive care unit. Crit. Care Med.2001,29,427-435
17. Hopfield, J.J. Artificial neural networks. IEEE Circuits Syst. Mag. 1988, 4,3-10
18. Jain, A.; Mao, J.; Mohiuddin, K. Artificial neural networks: A tutorial. Computer1996, 29, 31-44.
19. Moore, K.L. Automated radiotherapy treatment planning. In Seminars in Radiation Oncology; WB Saunders: Philadelphia, PA, USA, 2019; Volume 29, pp. 209-218.
20. Arimura, H.; Soufi M.; Kamezawa, H.; Ninomiya, K.; Yamada, M . Radiomics with artificial intelligence for precision medicine in radiation therapy. J. Radiat. Res. 2019,60 150-157.
21. Schmidt- Erfurth, U.; Sadeghipour, A.; Gerendas, B, S.; Waldstein, S .M.; Bogunovic, H. Artificial intelligence in retina. Prog. Retin. Eye Res. 2081,67, 1-29.
22. Troulis, M.; Everett, P.; Seldin, E.; Kikinis, R.; Kaban, L. Development of a three-dimensional treatment planning system based on computer tomographic data. Int. J. Oral Maxillofac. Surg. 2002, 31, 349-357.
23. Posner, M.I.; Rothbart, M.K. Research on Attention Network as a Model for the Integration of the Integration of Psychological Science. Annu. Rev. Psychol. 2007, 58, 1-23.
24. Haag, M.; Maylein, L.; Leven, F.J.; Tonshoff, B.; Haux, R. Web-based training: A new paradigm in computer-assisted instruction in medicine. Int. J. Med. Inform. 1999, 53, 79-90.
25. Ellahham, S. Artificial Intelligence: The Future for Diabetes Care. Am. J. Med.2020, 133, 895-900.
26. Telemedicine : Centers for Medicare & Medicaid service;. Available : https:// www.Medicaid.gov/ Medicaid/ benefits/ telemedicine/ index . Html
27. Keesara S, Jonas A, Schulman K. Covid-19 and health care’s digital revolution. N Engl J Med 2020;382:e82.
28. Zundel KM. Telemedicine: history, applications, and impact on librarianship. Bull Med Libr Assoc 1996;84: 71-9.
29. Hurst EJ. Evolutions in telemedicine: from smoke signals to mobile health solution. J Hosp Librariansh 2016;16:174-85.
30. Huss, R. The High Price of Failed Clinical Trial: Time to Rethink the Model. Clinical Leader,3 October 2016. Available online: http:// www.clinicalleader.com/doc/ the-high-price-of-failed-clinical-trails-time-to-rethink-the-model-0001
31. Goldsack, J. Synthetic Control Arms Can Save Time and Money in Clinical Trials. 2019. Available online: https:// www.statnews.com/2019/02/05/synthetic-control-arms-clinical-trial/
32. Unger, J.M.; Vaidya, R.; Hershman, D.L.; Minasian, L.M.; E Fleury, M. Systematic Review and Meta- Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Trial Participation. Gynecol. Oncol. 2019,111,245-255.
33. Kolluri,S.; Lin, R,; Zhang, Y.; Zhang, W. Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: A Review. AAPS J. 2022, 24,19.
34. Harrer, S.; Shan, P.; Antony ,B.; Hu,J. Artificial Intelligence for Clinical Trial Design. Trends Pharmacol. Sci. 2019,40,577-591.
35. Li, M.; Lin, R.;Lin, J.; Bunn, V.; Zhao, H. Bayesian Semi- parametric Desigh (BSD) for adaptive dose-finding with multiple strata. J. Biopharm. Stat. 2020, 30, 806-820.
36. Lin,R.; Lin, J.; Li, P. Design considerations for phase I/II dose finding clinical trial in Immuno-oncology and cell therapy. Contemp. Clin. Trials 2020, 96, 106083.